Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: Personalized Atrial Fibrillation Ablation Guided by Non-Invasive Global Mapping [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate a personalized atrial fibrillation ablation approach guided by non-invasive global mapping.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: German Heart Institute | Conditions: Atrial Fibrillation (AF) | NA | Status: RECRUITING